A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...

The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

"attachment_1199068" align="aligncenter" width="1456"] A pharmacy worker distributing prescription medicines to ...

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava ...

This week's episode covers news about Sarepta, babies born following mitochondrial transfer, and AI identifying therapy ...

On July 22, 2025, famed heavy metal singer Ozzy Osbourne died at age 76. Although his family did not release a cause of death ...

Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...

In the latest trading session, Astrazeneca (AZN) closed at $72.66, marking a -1.38% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.4%. Elsewhere, the Dow ...